tiprankstipranks
Generic Sweden AB (SE:GENI)
:GENI
Sweden Market
GENI
Generic Sweden AB
RESEARCH TOOLSreports

Generic Sweden AB (GENI) Income Statement

1 Followers

Generic Sweden AB Income Statement

Last quarter (Q4 2025), Generic Sweden AB's total revenue was kr49.23M, an increase of 2.99% from the same quarter last year. In Q4, Generic Sweden AB's net income was kr7.96M. See Generic Sweden AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 183.71Mkr 176.45Mkr 142.59Mkr 127.73Mkr 114.23M
Gross Profit
kr 38.58Mkr 44.72Mkr 38.27Mkr 35.54Mkr 31.93M
Operating Expenses
kr 0.00kr 11.38Mkr 10.15Mkr 9.78Mkr 9.09M
Depreciation and Amortization
kr 998.00Kkr 1.16Mkr 774.00Kkr 980.00Kkr 1.31M
EBITDA
kr 39.58Mkr 35.52Mkr 30.16Mkr 26.75Mkr 24.16M
Operating Income
kr 38.58Mkr 33.31Mkr 28.62Mkr 25.76Mkr 22.84M
Other Income/Expenses
kr 550.00Kkr 1.03Mkr 760.00Kkr 6.00Kkr 11.00K
Pretax Income
kr 39.13Mkr 34.35Mkr 29.38Mkr 25.77Mkr 22.85M
Net Income
kr 31.04Mkr 27.25Mkr 23.31Mkr 20.45Mkr 18.13M
Per Share Metrics
Basic EPS
kr 2.52kr 2.21kr 1.90kr 1.66kr 1.47
Diluted EPS
kr 2.52kr 2.21kr 1.90kr 1.66kr 1.47
Weighted Average Shares Outstanding
 12.29M 12.29M 12.27M 12.29M 12.29M
Weighted Average Shares Outstanding (Diluted)
 12.29M 12.29M 12.27M 12.32M 12.33M
Currency in SEK

Generic Sweden AB Earnings and Revenue History